|
#17
| |||
| |||
| On Jun 17, 10:32 pm, MattLB <mat...[at]angelfire.com> wrote: - quote - > > Anyway MattLB, to contribute to this thread in a constructive way tell
Perhaps I can supply my answer to this question - when AA is released> > us what is your idea of the molecular mechanism by which VitC enhances > > immunity and fights infections in the body? > > That's not what the thread's about so it would be veering off the > topic, even if I had a quick answer for you, which I don't. by the PLA2 action it stimulates inflammation. Freed AA is just more substrate for 5-LOX and later COX-1,2 to make the pro-inflammatory eicosanoids. Inflammation is not targeted to any particular germ, it just happens where AA is released and metabolized into the eicosanoids. Anti-germ antibodies can stimulate AA release at the places where germs are present at best. AA is also released by mechanical tissue damage. Killing the germs also takes bite on the own tissues which are repaired afterwards. VitC helps fighting the cold because it stimulates the release of even more AA than the germs could do on their own. This induces powerful inflammatory response which kills the germs quicker but also substantially damages own tissues such as the mucous membranes which take longer time to heal afterwards (you know the long-lasting colds). Well, as Monty has been pointing out, some common "germs" are better be treated as symbionts without taking such powerful substances such as AA to start war with them and turning them into ugly clingy attackers. I hope you got it right, I am saying that VitC acts like a non-specific immunostimulant by freeing more AA (something like the prolactin hormone in the end effect) - this is backed by my original citation. And people are doing crazy things like boosting the AA release by VitC and inhibiting AA metabolisation by aspirin/tylenol at the same time - same as consuming Omega-6 vegetable oils and then counteracting their negative effects with Omega-3 oils. Taka |
|
#16
| |||
| |||
| Taka wrote: - quote - > On Jun 17, 12:16 am, MattLB <mat...[at]angelfire.com> wrote:
One PUFA radical can start a chain reaction affecting many others> > On Jun 13, 5:06 pm, Taka <taka0...[at]gmail.com> wrote: > > > Like our wonderful PUFAs. BTW you forgot oxygen without which iron is > > > powerless. > > > > Not true. Iron can react with lipid hydroperoxides and others without > > the presence of oxygen. > > Without oxygen, 1 molecule Fe can oxidize 1 molecule PUFA but if > oxygen is present 1 molecule of Fe can catalyze the oxidation of > thousands of PUFA molecules (of course if you have thousands of O2 > molecules). (dependent on antioxidant status), regardless of oxygen levels. I'm surprised you didn't know that. - quote - > Well I guess VitC can produce AGEs as well, but most of them are
You can guess all you want, but that doesn't make your original> derived from PUFAs anyway. comments any more true. - quote - > > > I have mentioned previously how sugar and saturated fatty acids (which
Any time insulin levels are low, hormone sensitive lipases in the> > > are rare in their free form in the body BTW) > > > > Only when insulin levels are high. At other times, especially on low > > carb diets, levels of free FA are high. > > Never heard of that, triglycerides yes but free FAs floating in the > blood? Perhaps you mean chylomicrons? adipose tissue break down TGs into free fatty acids. These enter the blood and are transported via albumin throughout the body. The reason type I diabetics have acidosis is that the huge number of free fatty acid molecules reaching the liver overwhelm its ability to burn them, so lots of ketone bodies are produced as a side product. - quote - > Anyway MattLB, to contribute to this thread in a constructive way tell
That's not what the thread's about so it would be veering off the> us what is your idea of the molecular mechanism by which VitC enhances > immunity and fights infections in the body? topic, even if I had a quick answer for you, which I don't. MattLB |
|
#15
| |||
| |||
| On Jun 16, 4:06 am, "DrollTroll" <fit...[at]optonline.net> wrote: - quote - > "Taka" <taka0...[at]gmail.com> wrote in message
Do you understand what catalysis is all about? O2 can oxidize PUFAs> > news:9b4f0d67-dc25-4f26-9a71-1f9b93edeed6[at]a1g2000hsb.googlegroups.com... > > > Small/appropriate VitC amount at the right place is good and essential > > for e.g. collagen synthesis. Large amount at the wrong place may be > > dangerous depending on the presence of Fe, PUFAs and the like. AFAIK > > there are fewer studies, if any, showing a proinflammatory properties > > of VitE. VitE protects from lipid peroxides while VitC may facilitate > > their formation. Since lipid peroxides are proapoptotic and activate > > p53 high doses of VitC are used intravenously to kill cancers. The > > genotoxicity of VitC was refuted later by an artificial system in > > vitro experiment which I wouldn't trust as much as the original > > Science paper: > > Well, the first cite I found in my boy scout googling "shows" that alpha > tocopherol all by its lonesome forms lipid peroxides. They even show a > mechanism. Vit C stops this. > So your "if any" remark is immediately refuted--apparently you did not > bother to read my cite. > Do you think this is the *only* cite of its kind, regarding Vit E?? Did I > get lucky? > iirc, I think even some of *your cites* discussed Vit E in this regard. > > And on what authority do you "trust" one study over another? Do you have > personal laboratory experience in the field, or have you compiled citations > of these articles, for putative credibility? > > And, how does one selectively deliver Vit C "to the right places"?? > > > > > > > Science 15 June 2001: > > Vol. 292. no. 5524, pp. 2083 - 2086 > > DOI: 10.1126/science.1059501 > > > Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous > > Genotoxins > > > Seon Hwa Lee, Tomoyuki Oe, Ian A. Blair* > > > Epidemiological data suggest that dietary antioxidants play a > > protective role against cancer. This has led to the proposal that > > dietary supplementation with antioxidants such as vitamin C (vit C) > > may be useful in disease prevention. However, vit C has proved to be > > ineffective in cancer chemoprevention studies. In addition, concerns > > have been raised over potentially deleterious transition metal ion- > > mediated pro-oxidant effects. We have now determined that vit C > > induces lipid hydroperoxide decomposition to the DNA-reactive > > bifunctional electrophiles 4-oxo-2-nonenal, 4,5-epoxy-2(E)-decenal, > > and 4-hydroxy-2-nonenal. The compound 4,5-Epoxy-2(E)-decenal is a > > precursor of etheno-2'-deoxyadenosine, a highly mutagenic lesion > > found > > in human DNA. Vitamin C-mediated formation of genotoxins from lipid > > hydroperoxides in the absence of transition metal ions could help > > explain its lack of efficacy as a cancer chemoprevention agent. > > > For you "Boy Scout chemists", do you have any idea what the transition > > metal ion- > > mediated pro-oxidant effects are? This is different from the PLA2 > > induction > > Boy-scout chemist or not, I know that acid lowers pH, hot water raises temp, > and reducing agents reduce, they don't oxidize. > > "transition metal ion mediated pro-oxidant effect" is self-explanatory. > Since you seem to be the expert, why don't you discuss the *mechanisms* by > which these ions oxidize? Or peroxidize? I would be genuinely interested > in a coherent explanation. > > For example, Fe3+ is more of an oxidant than Fe2+, by definition. Which > suggests, btw, that FeSO4 is a "safer" source of iron than FeCl3. > Vit C is famous for reducing Fe3+ to Fe2+. So how can this be *pro > oxidizing*?? Fe2+ may still be oxidizing, but markedly less than Fe3+ > > I can think of only one way Fe2+ could be made more oxidizing than Fe3+: > > There may be an enzyme that has a greater binding constant for Fe2+ than for > Fe3+. If this Fe2+(enzyme) complex is in fact the culprit in an oxidizing > or peroxidizing (pro-inflammatory?) process, then indeed Vit C would be > increasing pro-oxidation in this specific context. > > Which is not likely, because afaik, transition metals are buried inside > enzymes (metallo enzymes), and I don't recall ions often binding to enzymes > at active sites, for obvious reasons of poor regulatory control by > ubiquitously available ions. > > Mg2+ stabilizing ATP is of course a different story. > > And, you would be obligated to show that this transition metal ion-enzyme > complex exists. You, or one of those studies, referred to VitC-Fe complex; > I doubt if such a thing exists, just as intact FeCl3 in solution does not > exist. > > Transition metal complexes *do* in fact exist, strictly in the form of > coordination compounds, such as Cr(nicotinate)3. But this has nothing to do > with oxidation or reduction, but rather simple transport of Cr3+. > > Please cite mechanisms, if you are able to. These are much more informative > and convincing than dart-thrown abstracts. > -- > DT directly but this takes very long time, like drying the oil painting. The redox pair of unbound Fe and VitC greatly speeds up this reaction by recycling each other and producing high levels of ROS which react with PUFAs much faster that O2 alone. In this process the iron continuously shifts between Fe3+ and Fe2+ so both are bad. I recommend you read the previous thread about haptoglobin SNPs which increase free iron (bound iron is not of much problem): http://tinyurl.com/3gzfbd Also see here: http://pmid.us/17644791+16256097+15306193 http://pmid.us/15047650+18032779 Am J Clin Nutr. 2004 Nov;80(5):1194-200. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR Jr. Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis 55454, USA. BACKGROUND: Vitamin C acts as a potent antioxidant; however, it can also be a prooxidant and glycate protein under certain circumstances in vitro. These observations led us to hypothesize that a high intake of vitamin C in diabetic persons might promote atherosclerosis. OBJECTIVE: The objective was to examine the relation between vitamin C intake and mortality from cardiovascular disease. DESIGN: We studied the relation between vitamin C intake and mortality from total cardiovascular disease (n = 281), coronary artery disease (n = 175), and stroke (n = 57) in 1923 postmenopausal women who reported being diabetic at baseline. Diet was assessed with a food-frequency questionnaire at baseline, and subjects initially free of coronary artery disease were prospectively followed for 15 y. RESULTS: After adjustment for cardiovascular disease risk factors, type of diabetes medication used, duration of diabetes, and intakes of folate, vitamin E, and beta-carotene, the adjusted relative risks of total cardiovascular disease mortality were 1.0, 0.97, 1.11, 1.47, and 1.84 (P for trend < 0.01) across quintiles of total vitamin C intake from food and supplements. Adjusted relative risks of coronary artery disease were 1.0, 0.81, 0.99, 1.26, and 1.91 (P for trend = 0.01) and of stroke were 1.0, 0.52, 1.23, 2.22, and 2.57 (P for trend < 0.01). When dietary and supplemental vitamin C were analyzed separately, only supplemental vitamin C showed a positive association with mortality endpoints. Vitamin C intake was unrelated to mortality from cardiovascular disease in the nondiabetic subjects at baseline. CONCLUSION: A high vitamin C intake from supplements is associated with an increased risk of cardiovascular disease mortality in postmenopausal women with diabetes. PMID: 15531665 Am J Clin Nutr. 2003 Dec;78(6):1074-8. Vitamin C and cancer chemoprevention: reappraisal. Lee KW, Lee HJ, Surh YJ, Lee CY. Department of Food Science and Technology, School of Agricultural Biotechnology, Seoul National University, Seoul, South Korea. Several studies have reported that even a moderate daily dose of supplementary vitamin C (200 mg) induces the formation of genotoxins from lipid hydroperoxides, thereby resulting in DNA damage and initiation of carcinogenesis. However, other reports questioned the experimental designs used and suggested that the chemopreventive effects of vitamin C may be linked to the inhibition of tumor promotion as well as to the blocking of tumor initiation. In this article, we discuss issues of contention and some controversies related to the potential chemopreventive effects of vitamin C in carcinogenesis. PMID: 14668266 Taka |
|
#14
| |||
| |||
| On Jun 17, 12:16 am, MattLB <mat...[at]angelfire.com> wrote: - quote - > On Jun 13, 5:06 pm, Taka <taka0...[at]gmail.com> wrote:
Without oxygen, 1 molecule Fe can oxidize 1 molecule PUFA but if> > > On Jun 13, 9:33 pm, MattLB <mat...[at]angelfire.com> wrote: > > > Mentioning sugar is a > > > complete red herring. > > > Yet VitC is made from sugar, > > So are many other molecules that also don't have the metabolic > consequences of high sugar levels. > > > enters cells via the same receptors as > > sugar and its absorption is competitively inhibited by sugar ... > > All of which has nothing to do with what happens when they get inside > the cells. > > > > Any molecule that can become a free radical > > > through interaction with iron will have the same effect. > > > Like our wonderful PUFAs. BTW you forgot oxygen without which iron is > > powerless. > > Not true. Iron can react with lipid hydroperoxides and others without > the presence of oxygen. oxygen is present 1 molecule of Fe can catalyze the oxidation of thousands of PUFA molecules (of course if you have thousands of O2 molecules). - quote - > > The combination O2+Fe+VitC+PUFAs is the best setting for
Well I guess VitC can produce AGEs as well, but most of them are> > getting full spectrum of lipid hydroperoxides and free radicals and > > you can even get so called AGEs if you throw in sugars. > > Something sugars and vit C don't have in common you mean. derived from PUFAs anyway. - quote - > > I have mentioned previously how sugar and saturated fatty acids (which
Never heard of that, triglycerides yes but free FAs floating in the> > are rare in their free form in the body BTW) > > Only when insulin levels are high. At other times, especially on low > carb diets, levels of free FA are high. blood? Perhaps you mean chylomicrons? - quote - > MattLB
Anyway MattLB, to contribute to this thread in a constructive way tellus what is your idea of the molecular mechanism by which VitC enhances immunity and fights infections in the body? Taka |
|
#13
| |||
| |||
| On Jun 13, 5:06 pm, Taka <taka0...[at]gmail.com> wrote: - quote - > On Jun 13, 9:33 pm, MattLB <mat...[at]angelfire.com> wrote:
So are many other molecules that also don't have the metabolic> > Mentioning sugar is a > > complete red herring. > > Yet VitC is made from sugar, consequences of high sugar levels. - quote - > enters cells via the same receptors as
All of which has nothing to do with what happens when they get inside> sugar and its absorption is competitively inhibited by sugar ... the cells. - quote - > > Any molecule that can become a free radical
Not true. Iron can react with lipid hydroperoxides and others without> > through interaction with iron will have the same effect. > > Like our wonderful PUFAs. BTW you forgot oxygen without which iron is > powerless. the presence of oxygen. - quote - > The combination O2+Fe+VitC+PUFAs is the best setting for
Something sugars and vit C don't have in common you mean.> getting full spectrum of lipid hydroperoxides and free radicals and > you can even get so called AGEs if you throw in sugars. - quote - > I have mentioned previously how sugar and saturated fatty acids (which
Only when insulin levels are high. At other times, especially on low> are rare in their free form in the body BTW) carb diets, levels of free FA are high. MattLB |
|
#12
| |||
| |||
| "Taka" <taka0038[at]gmail.com> wrote in message news:9b4f0d67-dc25-4f26-9a71-1f9b93edeed6[at]a1g2000hsb.googlegroups.com... - quote - > Small/appropriate VitC amount at the right place is good and essential > for e.g. collagen synthesis. Large amount at the wrong place may be > dangerous depending on the presence of Fe, PUFAs and the like. AFAIK > there are fewer studies, if any, showing a proinflammatory properties > of VitE. VitE protects from lipid peroxides while VitC may facilitate > their formation. Since lipid peroxides are proapoptotic and activate > p53 high doses of VitC are used intravenously to kill cancers. The > genotoxicity of VitC was refuted later by an artificial system in > vitro experiment which I wouldn't trust as much as the original > Science paper: Well, the first cite I found in my boy scout googling "shows" that alpha tocopherol all by its lonesome forms lipid peroxides. They even show a mechanism. Vit C stops this. So your "if any" remark is immediately refuted--apparently you did not bother to read my cite. Do you think this is the *only* cite of its kind, regarding Vit E?? Did I get lucky? iirc, I think even some of *your cites* discussed Vit E in this regard. And on what authority do you "trust" one study over another? Do you have personal laboratory experience in the field, or have you compiled citations of these articles, for putative credibility? And, how does one selectively deliver Vit C "to the right places"?? - quote - >
Boy-scout chemist or not, I know that acid lowers pH, hot water raises temp,> Science 15 June 2001: > Vol. 292. no. 5524, pp. 2083 - 2086 > DOI: 10.1126/science.1059501 > > Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous > Genotoxins > > Seon Hwa Lee, Tomoyuki Oe, Ian A. Blair* > > Epidemiological data suggest that dietary antioxidants play a > protective role against cancer. This has led to the proposal that > dietary supplementation with antioxidants such as vitamin C (vit C) > may be useful in disease prevention. However, vit C has proved to be > ineffective in cancer chemoprevention studies. In addition, concerns > have been raised over potentially deleterious transition metal ion- > mediated pro-oxidant effects. We have now determined that vit C > induces lipid hydroperoxide decomposition to the DNA-reactive > bifunctional electrophiles 4-oxo-2-nonenal, 4,5-epoxy-2(E)-decenal, > and 4-hydroxy-2-nonenal. The compound 4,5-Epoxy-2(E)-decenal is a > precursor of etheno-2'-deoxyadenosine, a highly mutagenic lesion > found > in human DNA. Vitamin C-mediated formation of genotoxins from lipid > hydroperoxides in the absence of transition metal ions could help > explain its lack of efficacy as a cancer chemoprevention agent. > > For you "Boy Scout chemists", do you have any idea what the transition > metal ion- > mediated pro-oxidant effects are? This is different from the PLA2 > induction and reducing agents reduce, they don't oxidize. "transition metal ion mediated pro-oxidant effect" is self-explanatory. Since you seem to be the expert, why don't you discuss the *mechanisms* by which these ions oxidize? Or peroxidize? I would be genuinely interested in a coherent explanation. For example, Fe3+ is more of an oxidant than Fe2+, by definition. Which suggests, btw, that FeSO4 is a "safer" source of iron than FeCl3. Vit C is famous for reducing Fe3+ to Fe2+. So how can this be *pro oxidizing*?? Fe2+ may still be oxidizing, but markedly less than Fe3+ I can think of only one way Fe2+ could be made more oxidizing than Fe3+: There may be an enzyme that has a greater binding constant for Fe2+ than for Fe3+. If this Fe2+(enzyme) complex is in fact the culprit in an oxidizing or peroxidizing (pro-inflammatory?) process, then indeed Vit C would be increasing pro-oxidation in this specific context. Which is not likely, because afaik, transition metals are buried inside enzymes (metallo enzymes), and I don't recall ions often binding to enzymes at active sites, for obvious reasons of poor regulatory control by ubiquitously available ions. Mg2+ stabilizing ATP is of course a different story. And, you would be obligated to show that this transition metal ion-enzyme complex exists. You, or one of those studies, referred to VitC-Fe complex; I doubt if such a thing exists, just as intact FeCl3 in solution does not exist. Transition metal complexes *do* in fact exist, strictly in the form of coordination compounds, such as Cr(nicotinate)3. But this has nothing to do with oxidation or reduction, but rather simple transport of Cr3+. Please cite mechanisms, if you are able to. These are much more informative and convincing than dart-thrown abstracts. -- DT - quote - > > Taka |
|
#11
| |||
| |||
| "Taka" <taka0038[at]gmail.com> wrote in message news:9b4f0d67-dc25-4f26-9a71-1f9b93edeed6[at]a1g2000hsb.googlegroups.com... - quote - > Small/appropriate VitC amount at the right place is good and essential
That's right Taka, iv administration can kill cancer cells and given that> for e.g. collagen synthesis. Large amount at the wrong place may be > dangerous depending on the presence of Fe, PUFAs and the like. AFAIK > there are fewer studies, if any, showing a proinflammatory properties > of VitE. VitE protects from lipid peroxides while VitC may facilitate > their formation. Since lipid peroxides are proapoptotic and activate > p53 high doses of VitC are used intravenously to kill cancers. The > genotoxicity of VitC was refuted later by an artificial system in > vitro experiment which I wouldn't trust as much as the original > Science paper: cancers have high expression of hsps, particularly if one of those is HO32, which may increase the free mitochondrial iron pool, and that vitamin C itself does this, perhaps via upregulated HO32(don't know), it is not that surprising that iv administration can facilitate cancer cell death, though I suspect by necrosis not apoptosis. Oral administration won't work because once tissue saturation is reached the rest of the vit C is not absorbed. To maximise the effect I wonder if iron administration would also be a good idea. - quote - > Science 15 June 2001: > Vol. 292. no. 5524, pp. 2083 - 2086 > DOI: 10.1126/science.1059501 > > Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous > Genotoxins > > Seon Hwa Lee, Tomoyuki Oe, Ian A. Blair* > > Epidemiological data suggest that dietary antioxidants play a > protective role against cancer. This has led to the proposal that > dietary supplementation with antioxidants such as vitamin C (vit C) > may be useful in disease prevention. However, vit C has proved to be > ineffective in cancer chemoprevention studies. In addition, concerns > have been raised over potentially deleterious transition metal ion- > mediated pro-oxidant effects. We have now determined that vit C > induces lipid hydroperoxide decomposition to the DNA-reactive > bifunctional electrophiles 4-oxo-2-nonenal, 4,5-epoxy-2(E)-decenal, > and 4-hydroxy-2-nonenal. The compound 4,5-Epoxy-2(E)-decenal is a > precursor of etheno-2'-deoxyadenosine, a highly mutagenic lesion > found > in human DNA. Vitamin C-mediated formation of genotoxins from lipid > hydroperoxides in the absence of transition metal ions could help > explain its lack of efficacy as a cancer chemoprevention agent. > > For you "Boy Scout chemists", do you have any idea what the transition > metal ion- > mediated pro-oxidant effects are? This is different from the PLA2 > induction > > Taka |
|
#10
| |||
| |||
| Small/appropriate VitC amount at the right place is good and essential for e.g. collagen synthesis. Large amount at the wrong place may be dangerous depending on the presence of Fe, PUFAs and the like. AFAIK there are fewer studies, if any, showing a proinflammatory properties of VitE. VitE protects from lipid peroxides while VitC may facilitate their formation. Since lipid peroxides are proapoptotic and activate p53 high doses of VitC are used intravenously to kill cancers. The genotoxicity of VitC was refuted later by an artificial system in vitro experiment which I wouldn't trust as much as the original Science paper: Science 15 June 2001: Vol. 292. no. 5524, pp. 2083 - 2086 DOI: 10.1126/science.1059501 Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous Genotoxins Seon Hwa Lee, Tomoyuki Oe, Ian A. Blair* Epidemiological data suggest that dietary antioxidants play a protective role against cancer. This has led to the proposal that dietary supplementation with antioxidants such as vitamin C (vit C) may be useful in disease prevention. However, vit C has proved to be ineffective in cancer chemoprevention studies. In addition, concerns have been raised over potentially deleterious transition metal ion- mediated pro-oxidant effects. We have now determined that vit C induces lipid hydroperoxide decomposition to the DNA-reactive bifunctional electrophiles 4-oxo-2-nonenal, 4,5-epoxy-2(E)-decenal, and 4-hydroxy-2-nonenal. The compound 4,5-Epoxy-2(E)-decenal is a precursor of etheno-2'-deoxyadenosine, a highly mutagenic lesion found in human DNA. Vitamin C-mediated formation of genotoxins from lipid hydroperoxides in the absence of transition metal ions could help explain its lack of efficacy as a cancer chemoprevention agent. For you "Boy Scout chemists", do you have any idea what the transition metal ion- mediated pro-oxidant effects are? This is different from the PLA2 induction Taka |
|
#9
| |||
| |||
| "John Hasenkam" <johnh[at]goawayplease.com> wrote in message news:7-idnaWzgq3MXs7VnZ2dnUVZ8vWdnZ2d[at]westnet.com.au... - quote - > In the context of a large free iron pool(and possibly other metals)
If Vit C *lowers* oxidation numbers (probably on all the transition metals,> vitamin C might be pro-inflammatory. Otherwise ... Don't sweat PLA2 so > much, it is even released via glutamate activity, as is AA. Both help. > Balance, concentrations, context, not presence or absence. Fe and Cu among them), why would that be pro-inflammatory? And what is "pro-inflammatory" anyway? Pro-oxidative? -- DT - quote - > > > "Marshall Price" <d021317c[at]yahoo.com> wrote in message > news:raqdnWzghfEv6czVnZ2dnUVZ_oTinZ2d[at]earthlink.com... > > Taka wrote: > > > Similar in structure and effects to sugar ... > > > Taka > > > > > > Mol Cell Biochem. 2008 May 22. > > > > > > Redox-active antioxidant modulation of lipid signaling in vascular > > > endothelial cells: vitamin C induces activation of phospholipase D > > > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > > > > > Steinhour E, Sherwani SI, Mazerik JN, Ciapala V, O'Connor Butler E, > > > Cruff JP, Magalang U, Parthasarathy S, Sen CK, Marsh CB, Kuppusamy P, > > > Parinandi NL. > > > Lipid Signaling and Lipidomics Laboratory, Division of Pulmonary, > > > Allergy, Critical Care, and Sleep Medicine, Department of Medicine, > > > College of Medicine, The Ohio State University, Columbus, OH, USA. > > > > > > We have earlier reported that the redox-active antioxidant, vitamin C > > > (ascorbic acid), activates the lipid signaling enzyme, phospholipase D > > > (PLD), at pharmacological doses (mM) in the bovine lung microvascular > > > endothelial cells (BLMVECs). However, the activation of phospholipase > > > A(2) (PLA(2)), another signaling phospholipase, and the modulation of > > > PLD activation by PLA(2) in the ECs treated with vitamin C at > > > pharmacological doses have not been reported to date. Therefore, this > > > study aimed at the regulation of PLD activation by PLA(2) in the > > > cultured BLMVECs exposed to vitamin C at pharmacological > > > concentrations. The results revealed that vitamin C (3-10 mM) > > > significantly activated PLA(2) starting at 30 min; however, the > > > activation of PLD resulted only at 120 min of treatment of cells under > > > identical conditions. Further studies were conducted utilizing > > > specific pharmacological agents to understand the mechanism(s) of > > > activation of PLA(2) and PLD in BLMVECs treated with vitamin C (5 mM) > > > for 120 min. Antioxidants, calcium chelators, iron chelators, and > > > PLA(2) inhibitors offered attenuation of the vitamin C-induced > > > activation of both PLA(2) and PLD in the cells. Vitamin C was also > > > observed to significantly induce the formation and release of the > > > cyclooxygenase (COX)- and lipoxygenase (LOX)-catalyzed arachidonic > > > acid (AA) metabolites and to activate the AA LOX in BLMVECs. The > > > inhibitors of PLA(2), COX, and LOX were observed to effectively and > > > significantly attenuate the vitamin C-induced PLD activation in > > > BLMVECs. For the first time, the results of the present study revealed > > > that the vitamin C-induced activation of PLD in vascular ECs was > > > regulated by the upstream activation of PLA(2), COX, and LOX through > > > the formation of AA metabolites involving oxidative stress, calcium, > > > and iron. > > > PMID: 18496733 > > > > Come on, Taka. You chose the subject line, and you said "similar in > > structure and effects to sugar," and this is a discussion group, so how > > about some discussion? > > > > Sugar has 12 carbons; ascorbic acid has six. Sugar provides quick > > energy, ascorbic acid provides none. Most antioxidants are > > anti-inflammatory; ascorbic acid is an antioxidant, but you say it's > > "proinflammatory." > > > > Surely you realize this stuff is hard reading or incomprehensible to > > almost everybody in this newsgroup but you, so please help us understand > > what it says and why you said what you did. > > > > -- > > Marshall Price of Miami > > Known to Yahoo as d021317c > > |
|
#8
| |||
| |||
| In the context of a large free iron pool(and possibly other metals) vitamin C might be pro-inflammatory. Otherwise ... Don't sweat PLA2 so much, it is even released via glutamate activity, as is AA. Both help. Balance, concentrations, context, not presence or absence. "Marshall Price" <d021317c[at]yahoo.com> wrote in message news:raqdnWzghfEv6czVnZ2dnUVZ_oTinZ2d[at]earthlink.com... - quote - > Taka wrote: > > Similar in structure and effects to sugar ... > > Taka > > > > Mol Cell Biochem. 2008 May 22. > > > > Redox-active antioxidant modulation of lipid signaling in vascular > > endothelial cells: vitamin C induces activation of phospholipase D > > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > > > Steinhour E, Sherwani SI, Mazerik JN, Ciapala V, O'Connor Butler E, > > Cruff JP, Magalang U, Parthasarathy S, Sen CK, Marsh CB, Kuppusamy P, > > Parinandi NL. > > Lipid Signaling and Lipidomics Laboratory, Division of Pulmonary, > > Allergy, Critical Care, and Sleep Medicine, Department of Medicine, > > College of Medicine, The Ohio State University, Columbus, OH, USA. > > > > We have earlier reported that the redox-active antioxidant, vitamin C > > (ascorbic acid), activates the lipid signaling enzyme, phospholipase D > > (PLD), at pharmacological doses (mM) in the bovine lung microvascular > > endothelial cells (BLMVECs). However, the activation of phospholipase > > A(2) (PLA(2)), another signaling phospholipase, and the modulation of > > PLD activation by PLA(2) in the ECs treated with vitamin C at > > pharmacological doses have not been reported to date. Therefore, this > > study aimed at the regulation of PLD activation by PLA(2) in the > > cultured BLMVECs exposed to vitamin C at pharmacological > > concentrations. The results revealed that vitamin C (3-10 mM) > > significantly activated PLA(2) starting at 30 min; however, the > > activation of PLD resulted only at 120 min of treatment of cells under > > identical conditions. Further studies were conducted utilizing > > specific pharmacological agents to understand the mechanism(s) of > > activation of PLA(2) and PLD in BLMVECs treated with vitamin C (5 mM) > > for 120 min. Antioxidants, calcium chelators, iron chelators, and > > PLA(2) inhibitors offered attenuation of the vitamin C-induced > > activation of both PLA(2) and PLD in the cells. Vitamin C was also > > observed to significantly induce the formation and release of the > > cyclooxygenase (COX)- and lipoxygenase (LOX)-catalyzed arachidonic > > acid (AA) metabolites and to activate the AA LOX in BLMVECs. The > > inhibitors of PLA(2), COX, and LOX were observed to effectively and > > significantly attenuate the vitamin C-induced PLD activation in > > BLMVECs. For the first time, the results of the present study revealed > > that the vitamin C-induced activation of PLD in vascular ECs was > > regulated by the upstream activation of PLA(2), COX, and LOX through > > the formation of AA metabolites involving oxidative stress, calcium, > > and iron. > > PMID: 18496733 > > Come on, Taka. You chose the subject line, and you said "similar in > structure and effects to sugar," and this is a discussion group, so how > about some discussion? > > Sugar has 12 carbons; ascorbic acid has six. Sugar provides quick > energy, ascorbic acid provides none. Most antioxidants are > anti-inflammatory; ascorbic acid is an antioxidant, but you say it's > "proinflammatory." > > Surely you realize this stuff is hard reading or incomprehensible to > almost everybody in this newsgroup but you, so please help us understand > what it says and why you said what you did. > > -- > Marshall Price of Miami > Known to Yahoo as d021317c |
|
#7
| |||
| |||
| On Jun 14, 4:07 am, "DrollTroll" <fit...[at]optonline.net> wrote: - quote - > Highly unlikely, as per my response to MattLB.
So how would you explain the numerous studies using VitC to oxidize> VitC (fresh Vit C, at any rate) is a reducing agent, likely rendering O2, Fe > etc. unable to oxidize pufa's. It is a kind of sacrificial molecule, PUFAs in vitro and its genotoxic effects in vivo? E.g.: Mol-Cell-Biochem. 1997 Apr; 169(1-2): 171-6 In vitro influence of ascorbate on lipid peroxidation in rat testis and heart microsomes. Lipid peroxidation (LPO) in rat testis and heart microsomes was compared using the ADP/Fe2+ as initiator with and without ascorbate at different concentrations. The extent of LPO was estimated by the levels of TBARS and PUFA. Without ascorbate, LPO was higher in heart than in testis despite elevated levels of catalase in heart. With increased ascorbate concentrations, a biphasic effect of LPO was observed. For a concentration less than or = 0.2 mM, ascorbate acted as pro-oxidant and increased TBARS correlated with decreased PUFA were observed both in testis and heart. Above 0.2 mM, ascorbate acts as antioxidant but differences in the rate of LPO were observed. In heart decreased TBARS correlated with increased PUFA whereas in testis TBARS only decreased, PUFA were not significantly modified. These results suggest different mechanisms in LPO initiation in the two organs. Increasing concentrations of H2O2 produced directly elevated TBARS levels in testis while a lag phase was observed in heart before the increase, suggesting that H2O2 was the essential ROS produced by ascorbate-ADP/Fe2+. The effects of scavengers such as catalase and ethanol showed an inhibitory effect on TBARS production only in testis, suggesting the role of H2O2/OH. as an initiator of LPO. In heart, catalase produced a slight increase in TBARS levels whereas no modification was observed with ethanol, suggesting a possible direct activation by ADP/Fe2+ through a metal-oxo intermediate. http://dx.doi.org/10.1016/S0278-6915(03)00164-9 Induction of lipid peroxidation in biomembranes by dietary oil components Prooxidant formation and resulting lipid peroxidation are supposed to be involved in the pathogenesis of various diseases including cancer. Cancer risk is possibly influenced by the composition of diet with high intake of fat and red meat being harmful and high consumption of fruits and vegetables being protective. Since dietary oils may contain potential prooxidants, the aim of the present study was to prove (i) whether oxidative stress in biomembranes may be induced by dietary oils and if, (ii) which impact it has on the viability and proliferation of cultured colon (carcinoma) cells. Lipid hydroperoxide content in dietary oils increased after heating. Linoleic acid hydroperoxide (LOOH) and/or oils with different hydroperoxide contents induced lipid peroxidation in liposomes, erythrocyte ghosts and colon cells. Upon incubation with liposomes, both LOOH and heated oil induced lipid peroxidation only in the presence of iron and ****** ascorbate *******. LOOH was sufficient to start lipid peroxidation of erythrocyte ghosts. LOOH incorporates into the lipid bilayer decreasing membrane fluidity and initiating lipid peroxidation in the lipid phase. When cultured cells (IEC18 intestinal epithelial cells, SW480 and HT29/HI1 colon carcinoma cells) were exposed to LOOH, they responded by cell death both via apoptosis and necrosis. Cells with higher degree of membrane unsaturation were more susceptible and antioxidants (vitamin E and selenite) were protective indicating the involvement of oxidative stress. Thus, peroxidation of biomembranes can be initiated by lipid hydroperoxides from heated oils. Dietary consumption of heated oils may lead to oxidative damage and to cell death in the colon. This may contribute to the enhanced risk of colon cancer due to regenerative cell proliferation. http://dx.doi.org/10.1016/S0009-3084(97)00038-8 Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach There is strong evidence that the oxidation of plasma lipoproteins plays an important role in atherogenesis. The exact mechanisms by which lipoprotein oxidation occurs in the presence of other plasma constituents, however, remains unclear. To investigate the role of different antioxidants for this process, we studied the oxidation of human plasma supplemented in vitro with physiological amounts of major plasma antioxidants -tocopherol, ubiquinol-10, ascorbate, urate, bilirubin and albumin. The plasma was diluted 2-fold and oxidized by 3.75 mM Cu(II). The concentrations of the antioxidants, fatty acids, linoleic acid hydroperoxides and oxycholesterols in oxidizing plasma were measured. The oxidation was characterized by three consecutive phases similar to the known lag, propagation, and decomposition phases of low density lipoprotein oxidation. The rate of the initiation of oxidation as calculated from antioxidant consumption rates was raised by supplementation with -tocopherol or ascorbate. The oxidation rate in the lag phase was lowered by supplementation with any of the antioxidants, whereas in the propagation phase the oxidation rate was slightly higher in supplemented than in unsupplemented plasma. The kinetic chain length in the lag phase was less than one in supplemented plasma and about one in unsupplemented plasma. The chain length in the propagation phase was between three and six for all plasma samples. A higher rate of urate consumption and a reduced rate of -tocopherol consumption were found in plasma supplemented with ascorbate in comparison with unsupplemented plasma. These data suggest that: (i) the reduction of Cu(II) by -tocopherol and ascorbate is a major initiating event in Cu(II)-catalyzed oxidation of human plasma; (ii) the following lag phase is caused by radical-scavenging effects of all antioxidants with -tocopherol as a major lipophilic and urate as a major hydrophilic scavenger; (iii) interactions between antioxidants, such as regeneration of ascorbate by urate and of - tocopherol by ascorbate, take place during the lag phase; (iv) in the absence of added antioxidants the oxidation in the lag phase can occur via a chain reaction; and (v) in the propagation phase the oxidation is not inhibited by antioxidants and occurs autocatalytically. J Lab Clin Med. 1989 Sep;114(3):243-9. Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha- tocopherol on myocardial lipid peroxidation. Link G, Pinson A, Kahane I, Hershko C. Department of Nutrition, Hebrew University Hadassah Medical School, Jerusalem, Israel. Increased generation of free radicals and accelerated lipid peroxidation are important manifestations of iron toxicity. We have studied the effect of iron loading on lipid peroxidation in cultured rat myocardial cells by direct measurement of the fatty acid composition of cellular lipids. Iron loading produced by 24-hour incubation of cultured cells with 0.36 mmol/L ferric ammonium citrate resulted in a moderate reduction in polyunsaturated fatty acids (PUFAs) such as 22:5 and 22:6. A more drastic reduction in PUFAs and an apparent reciprocal increase in the proportion of saturated fatty acids were both obtained after 24 hours of incubation of liposomal vesicles prepared from whole cell lipid extracts with iron at between pH 4.5 and pH 5.5. Reduction of 22:5 and 22:6 was first noticed at 3 hours, and undetectable levels were reached by 12 and 24 hours of incubation. Ascorbate had a biphasic effect on liposomal PUFA levels: at low concentrations (0.057 mmol/L) it enhanced the iron-induced changes in liposomal fatty acid composition, but at higher concentrations (0.57 and 5.7 mmol/L), it inhibited these changes. Unlike ascorbate, alpha-tocopherol (0.023 to 2.3 mmol/L) inhibited the iron-induced reduction in PUFAs in a dose-dependent manner, with complete inhibition of the iron effect at 2.3 mmol/L. These observations underline the particular sensitivity of PUFAs to iron- induced lipid peroxidation. They also illustrate the ability of ascorbate and alpha-tocopherol to modify iron-induced lipid peroxidation. Further studies are required to explore the possible therapeutic implications of these observations in clinical iron overload. PMID: 2769018 Int J Biochem Cell Biol. 1996 Feb;28(2):137-49. A possible mechanism for initiation of lipid peroxidation by ascorbate in rat liver microsomes. Casalino E, Sblano C, Landriscina C. Laboratory of Biochemistry, University of Bari, Italy. The mechanism by which lipid peroxidation progresses has been known for years, but there is disagreement regarding the mode of its initiation. The aim of this study was to examine: (a) the role of endogenous iron in the initiation of ascorbate-induced lipid peroxidation in microsomal and liposomal membranes; (b) the role of oxygen-free radicals in this process; and (c) the redox state of ascorbate during the course of lipid peroxidation. Ascorbate-induced lipid peroxidation was assessed by measuring hydroperoxide and thiobarbituric acid reactive substances (TBARS) formation in membranes after incubation in Tris-HCl buffer (pH 7.4) for 15 min. To confirm the role of endogenous iron and oxygen-free radicals, the effect of iron chelating agents (EDTA and thiourea) and radical scavengers (benzoate, mannitol, catalase and SOD) on lipid peroxidation was examined. Spectrophotometric measurements and ESR spectra have made it possible to determine ascorbate concentration and its redox state. Ascorbate promoted lipid peroxidation in both rat liver microsomes and liposomes without addition of exogenous iron. Iron chelating agents such as EDTA and thiourea inhibited lipid peroxidation, while SOD, catalase, mannitol and benzoate had no effect. The addition of 5 microM Fe2+ (or Fe3+) to the incubation mixture did not significantly alter hydroperoxide production, but that of TBARS was increased. Lipid peroxidation significantly altered the fatty acid profile in microsomes and liposomes, the most affected being the C20:4 and C22:6 species. Ascorbate in Tris-HCl buffer (pH 7.4) autoxidized very slowly. Its oxidation was catalyzed by Fe3+ ions at a rate determined by incubation time and iron concentration. In contrast, no ascorbate oxidation occurred in the presence of microsomes when lipid peroxidation was proceeding at a maximal rate. Under these conditions a typical ascorbyl radical ESR spectrum signal greater than that arising from ascorbate alone was obtained and the magnitude of this signal was unchanged by variations of microsome or ascorbate concentrations. A ferrous ion ascorbyl radical complex was responsible for this signal. These results suggest that ************ an ascorbate- microsomal iron complex is responsible for the initiation of lipid peroxidation, **************and that during this process ascorbate remains in its reduced form. PMID: 8729001 Taka |
|
#6
| |||
| |||
| "Taka" <taka0038[at]gmail.com> wrote in message news:22d34952-4edc-48d1-a477-0ad7efc82b7c[at]x1g2000prh.googlegroups.com... - quote - > On Jun 13, 9:33 pm, MattLB <mat...[at]angelfire.com> wrote: > > On Jun 12, 8:10 pm, Marshall Price <d0213...[at]yahoo.com> wrote: > > > > > Taka wrote: > > > > Similar in structure and effects to sugar ... > > > > Taka > > > > > > Mol Cell Biochem. 2008 May 22. > > > > > > Redox-active antioxidant modulation of lipid signaling in vascular > > > > endothelial cells: vitamin C induces activation of phospholipase D > > > > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > > Come on, Taka. You chose the subject line, and you said "similar in > > > structure and effects to sugar," and this is a discussion group, so how > > > about some discussion? > > > > Just another inflammatory (hoho) and disingenous headline from Taka, > > I'm afraid. > > > > Having looked briefly at the paper the whole thing is very non- > > specific. Basically when you raise blood levels of vitamin C to > > *pharmacological* levels by directly injecting Vit C into the > > bloodstream (i.e. not by eating supplements) you see increased > > activation of molecules involved in oxidative stress. > > > > In the presence of iron, vitamin C can become a free radical that can > > then damage other molecules and lead to activation of various enzymes. > > One of these causes the release of arachidonic acid within the cell. > > These is as specific as the connection is. > > And as specific as the chronic inflammatory states are ... > > > Mentioning sugar is a > > complete red herring. > > Yet VitC is made from sugar, enters cells via the same receptors as > sugar and its absorption is competitively inhibited by sugar ... > > > Any molecule that can become a free radical > > through interaction with iron will have the same effect. > > Like our wonderful PUFAs. BTW you forgot oxygen without which iron is > powerless. The combination O2+Fe+VitC+PUFAs is the best setting for > getting full spectrum of lipid hydroperoxides and free radicals and > you can even get so called AGEs if you throw in sugars. Highly unlikely, as per my response to MattLB. VitC (fresh Vit C, at any rate) is a reducing agent, likely rendering O2, Fe etc. unable to oxidize pufa's. It is a kind of sacrificial molecule, as are the conjugated systems of Vits A and E, beta carotene, CLA's, poss. some amino acids, etc. Altho structurally Vit C appears simple, it is actually subtlely complicated, having both pH effects AND redox effects, both of which are independent, iirc. It is a well-studied molecule, and you would have to *chemically support*, via a proposed mechanism, just how VitC would promote peroxide formation, when its putative function is directly opposite to this. re the VLCKD (kd = ketogenic diet?), seems to support atkins. Except that if this really is ketogenic, long term it screws up the body so badly that any specific lipid profiles are irrlevant. This has been proven in the military, and pregnant women on ketogenic diets wind up with brain damaged kids. Wonder why..... Big diff. between low carb and ketogenic. -- DT - quote - > > I have mentioned previously how sugar and saturated fatty acids (which > are rare in their free form in the body BTW) release AA: > > http://tinyurl.com/52y4kk > > http://tinyurl.com/4c6w9l > > And a recent article has been posted showing how the carbohydrate > restriction has antiinflammatory effects even in people full of AA: > > Lipids. 2008 Jan;43(1):65-77. Epub 2007 Nov 29. > > Comparison of low fat and low carbohydrate diets on circulating fatty > acid composition and markers of inflammation. > > Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, > Kraemer WJ, Feinman RD, Volek JS. > Department of Kinesiology, University of Connecticut, 2095 Hillside > Road, Unit 1110, Storrs, CT, 06269-1110, USA. > > Abnormal distribution of plasma fatty acids and increased inflammation > are prominent features of metabolic syndrome. We tested whether these > components of metabolic syndrome, like dyslipidemia and glycemia, are > responsive to carbohydrate restriction. Overweight men and women with > atherogenic dyslipidemia consumed ad libitum diets very low in > carbohydrate (VLCKD) (1504 kcal:%CHO:fat rotein = 12:59:28) or low in> fat (LFD) (1478 kcal:%CHO:fat rotein = 56:24:20) for 12 weeks. In> comparison to the LFD, the VLCKD resulted in an increased proportion > of serum total n-6 PUFA, mainly attributed to a marked increase in > arachidonate (20:4n-6), while its biosynthetic metabolic intermediates > were decreased. The n-6/n-3 and arachidonic/eicosapentaenoic acid > ratio also increased sharply. Total saturated fatty acids and 16:1n-7 > were consistently decreased following the VLCKD. Both diets > significantly decreased the concentration of several serum > inflammatory markers, but there was an overall greater anti- > inflammatory effect associated with the VLCKD, as evidenced by greater > decreases in TNF-alpha, IL-6, IL-8, MCP-1, E-selectin, I-CAM, and > PAI-1. Increased 20:4n-6 and the ratios of 20:4n-6/20:5n-3 and n-6/n-3 > are commonly viewed as pro-inflammatory, but unexpectedly were > consistently inversely associated with responses in inflammatory > proteins. In summary, a very low carbohydrate diet resulted in > profound alterations in fatty acid composition and reduced > inflammation compared to a low fat diet. > PMID: 18046594 > > Taka |
|
#5
| |||
| |||
| "MattLB" <mattlb[at]angelfire.com> wrote in message news:d6828707-c6e6-41fe-9c2e-3ffcfc2a394d[at]k30g2000hse.googlegroups.com... - quote - > On Jun 12, 8:10 pm, Marshall Price <d0213...[at]yahoo.com> wrote:
Not a likely scenario.> > Taka wrote: > > > Similar in structure and effects to sugar ... > > > Taka > > > > > Mol Cell Biochem. 2008 May 22. > > > > > Redox-active antioxidant modulation of lipid signaling in vascular > > > endothelial cells: vitamin C induces activation of phospholipase D > > > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > > Come on, Taka. You chose the subject line, and you said "similar in > > structure and effects to sugar," and this is a discussion group, so how > > about some discussion? > > Just another inflammatory (hoho) and disingenous headline from Taka, > I'm afraid. > > Having looked briefly at the paper the whole thing is very non- > specific. Basically when you raise blood levels of vitamin C to > *pharmacological* levels by directly injecting Vit C into the > bloodstream (i.e. not by eating supplements) you see increased > activation of molecules involved in oxidative stress. > > In the presence of iron, vitamin C can become a free radical that can > then damage other molecules and lead to activation of various enzymes. Vit C is actually an equilibrium solution between oxy- and de-oxy ascorbic acid, which are redox couples, whose specific purpose is "reducing" oxidative compounds, among them Fe3+ to Fe2+, and Cu2+ to Cu1+, which radically affects absorption rates of these minerals. iirc, this occurs via a reactive double bond in VitC reversibly converting to a single bond. Unlikely for C itself to become a free radical. -- DT - quote - > One of these causes the release of arachidonic acid within the cell. > These is as specific as the connection is. Mentioning sugar is a > complete red herring. Any molecule that can become a free radical > through interaction with iron will have the same effect. > > The experiments were also done using cells growing in flasks, with > vitamin C directly added to the cell medium, so have rather little > connection to the human body where the vitamin C is consumed along > with a host of other molecules. > > MattLB > |
|
#4
| |||
| |||
| On Jun 13, 9:33 pm, MattLB <mat...[at]angelfire.com> wrote: - quote - > On Jun 12, 8:10 pm, Marshall Price <d0213...[at]yahoo.com> wrote:
And as specific as the chronic inflammatory states are ...> > > Taka wrote: > > > Similar in structure and effects to sugar ... > > > Taka > > > > Mol Cell Biochem. 2008 May 22. > > > > Redox-active antioxidant modulation of lipid signaling in vascular > > > endothelial cells: vitamin C induces activation of phospholipase D > > > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > Come on, Taka. You chose the subject line, and you said "similar in > > structure and effects to sugar," and this is a discussion group, so how > > about some discussion? > > Just another inflammatory (hoho) and disingenous headline from Taka, > I'm afraid. > > Having looked briefly at the paper the whole thing is very non- > specific. Basically when you raise blood levels of vitamin C to > *pharmacological* levels by directly injecting Vit C into the > bloodstream (i.e. not by eating supplements) you see increased > activation of molecules involved in oxidative stress. > > In the presence of iron, vitamin C can become a free radical that can > then damage other molecules and lead to activation of various enzymes. > One of these causes the release of arachidonic acid within the cell. > These is as specific as the connection is. - quote - > Mentioning sugar is a
Yet VitC is made from sugar, enters cells via the same receptors as> complete red herring. sugar and its absorption is competitively inhibited by sugar ... - quote - > Any molecule that can become a free radical
Like our wonderful PUFAs. BTW you forgot oxygen without which iron is> through interaction with iron will have the same effect. powerless. The combination O2+Fe+VitC+PUFAs is the best setting for getting full spectrum of lipid hydroperoxides and free radicals and you can even get so called AGEs if you throw in sugars. I have mentioned previously how sugar and saturated fatty acids (which are rare in their free form in the body BTW) release AA: http://tinyurl.com/52y4kk http://tinyurl.com/4c6w9l And a recent article has been posted showing how the carbohydrate restriction has antiinflammatory effects even in people full of AA: Lipids. 2008 Jan;43(1):65-77. Epub 2007 Nov 29. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, Kraemer WJ, Feinman RD, Volek JS. Department of Kinesiology, University of Connecticut, 2095 Hillside Road, Unit 1110, Storrs, CT, 06269-1110, USA. Abnormal distribution of plasma fatty acids and increased inflammation are prominent features of metabolic syndrome. We tested whether these components of metabolic syndrome, like dyslipidemia and glycemia, are responsive to carbohydrate restriction. Overweight men and women with atherogenic dyslipidemia consumed ad libitum diets very low in carbohydrate (VLCKD) (1504 kcal:%CHO:fat rotein = 12:59:28) or low infat (LFD) (1478 kcal:%CHO:fat rotein = 56:24:20) for 12 weeks. Incomparison to the LFD, the VLCKD resulted in an increased proportion of serum total n-6 PUFA, mainly attributed to a marked increase in arachidonate (20:4n-6), while its biosynthetic metabolic intermediates were decreased. The n-6/n-3 and arachidonic/eicosapentaenoic acid ratio also increased sharply. Total saturated fatty acids and 16:1n-7 were consistently decreased following the VLCKD. Both diets significantly decreased the concentration of several serum inflammatory markers, but there was an overall greater anti- inflammatory effect associated with the VLCKD, as evidenced by greater decreases in TNF-alpha, IL-6, IL-8, MCP-1, E-selectin, I-CAM, and PAI-1. Increased 20:4n-6 and the ratios of 20:4n-6/20:5n-3 and n-6/n-3 are commonly viewed as pro-inflammatory, but unexpectedly were consistently inversely associated with responses in inflammatory proteins. In summary, a very low carbohydrate diet resulted in profound alterations in fatty acid composition and reduced inflammation compared to a low fat diet. PMID: 18046594 Taka |
|
#3
| |||
| |||
| On Jun 12, 8:10 pm, Marshall Price <d0213...[at]yahoo.com> wrote: - quote - > Taka wrote:
Just another inflammatory (hoho) and disingenous headline from Taka,> > Similar in structure and effects to sugar ... > > Taka > > > Mol Cell Biochem. 2008 May 22. > > > Redox-active antioxidant modulation of lipid signaling in vascular > > endothelial cells: vitamin C induces activation of phospholipase D > > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > Come on, Taka. You chose the subject line, and you said "similar in > structure and effects to sugar," and this is a discussion group, so how > about some discussion? I'm afraid. Having looked briefly at the paper the whole thing is very non- specific. Basically when you raise blood levels of vitamin C to *pharmacological* levels by directly injecting Vit C into the bloodstream (i.e. not by eating supplements) you see increased activation of molecules involved in oxidative stress. In the presence of iron, vitamin C can become a free radical that can then damage other molecules and lead to activation of various enzymes. One of these causes the release of arachidonic acid within the cell. These is as specific as the connection is. Mentioning sugar is a complete red herring. Any molecule that can become a free radical through interaction with iron will have the same effect. The experiments were also done using cells growing in flasks, with vitamin C directly added to the cell medium, so have rather little connection to the human body where the vitamin C is consumed along with a host of other molecules. MattLB |
|
#2
| |||
| |||
| On Jun 13, 4:10 am, Marshall Price <d0213...[at]yahoo.com> wrote: - quote - > Surely you realize this stuff is hard reading or incomprehensible to
To make long story short, AA needs to be converted to proinflammatory> almost everybody in this newsgroup but you, so please help us understand > what it says and why you said what you did. metabolites called eicosanoids to exert its immunity boosting and destructive effects. Before these metabolites can be created by the action of the 5-LOX and COX-1,2 enzymes, AA has to be released/cleaved off from the membrane phospholipids. This cleavage is done by the PLA2 enzymes which turn to be quite important in the regulation and localization of the inflammatory responses. You can read about them e.g. in Wikipedia: http://en.wikipedia.org/wiki/PLA2 Expressing PLA2 is like igniting your car engine, which can have different types of fuel in it (e.g. the gasoline with added sugar as Monty recently mentioned). Some pathogens explore this by expressing and excreting their own PLA2 enzymes which ignite powerful inflammatory responses in the affected tissues. I have found some papers posted previously showing that sugar and saturated fatty acids also upregulate PLA2. It's not as drastic as in the case of the pathogens or reaction to infection and tissue damage but enough to cause silent chronic inflammation. In the abovementioned paper VitC also stimulates PLA2 what is understandable given its immune-boosting effects. If you catch cold you drink VitC drink with added sugar, right? It will inflame your body what helps to kill the invading germs. Helps in the short term and if the germs are really bad but also damages your own tissues which need to be repaired afterwards. A better approach is to downregulate the inflammatory mediators derived from AA by ingesting COX inhibitors like ginger or EVO. Then there will be no tissue damage and the germs start behaving more like symbionts and decrease in number if they are not those nasty types which are better be killed with antibiotics anyway. The bottom line is VitC stimulates the release of AA at higher doses so it's foolish taking it as supplementary antioxidant when you have no need to boost your immunity. There are papers showing that VitC is even genotoxic what is likely caused by its reactions with Fe and PUFAs: http://tinyurl.com/66w78p Taka |
|
#1
| |||
| |||
| Taka wrote: - quote - > Similar in structure and effects to sugar ...
Come on, Taka. You chose the subject line, and you said "similar in> Taka > > Mol Cell Biochem. 2008 May 22. > > Redox-active antioxidant modulation of lipid signaling in vascular > endothelial cells: vitamin C induces activation of phospholipase D > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > Steinhour E, Sherwani SI, Mazerik JN, Ciapala V, O'Connor Butler E, > Cruff JP, Magalang U, Parthasarathy S, Sen CK, Marsh CB, Kuppusamy P, > Parinandi NL. > Lipid Signaling and Lipidomics Laboratory, Division of Pulmonary, > Allergy, Critical Care, and Sleep Medicine, Department of Medicine, > College of Medicine, The Ohio State University, Columbus, OH, USA. > > We have earlier reported that the redox-active antioxidant, vitamin C > (ascorbic acid), activates the lipid signaling enzyme, phospholipase D > (PLD), at pharmacological doses (mM) in the bovine lung microvascular > endothelial cells (BLMVECs). However, the activation of phospholipase > A(2) (PLA(2)), another signaling phospholipase, and the modulation of > PLD activation by PLA(2) in the ECs treated with vitamin C at > pharmacological doses have not been reported to date. Therefore, this > study aimed at the regulation of PLD activation by PLA(2) in the > cultured BLMVECs exposed to vitamin C at pharmacological > concentrations. The results revealed that vitamin C (3-10 mM) > significantly activated PLA(2) starting at 30 min; however, the > activation of PLD resulted only at 120 min of treatment of cells under > identical conditions. Further studies were conducted utilizing > specific pharmacological agents to understand the mechanism(s) of > activation of PLA(2) and PLD in BLMVECs treated with vitamin C (5 mM) > for 120 min. Antioxidants, calcium chelators, iron chelators, and > PLA(2) inhibitors offered attenuation of the vitamin C-induced > activation of both PLA(2) and PLD in the cells. Vitamin C was also > observed to significantly induce the formation and release of the > cyclooxygenase (COX)- and lipoxygenase (LOX)-catalyzed arachidonic > acid (AA) metabolites and to activate the AA LOX in BLMVECs. The > inhibitors of PLA(2), COX, and LOX were observed to effectively and > significantly attenuate the vitamin C-induced PLD activation in > BLMVECs. For the first time, the results of the present study revealed > that the vitamin C-induced activation of PLD in vascular ECs was > regulated by the upstream activation of PLA(2), COX, and LOX through > the formation of AA metabolites involving oxidative stress, calcium, > and iron. > PMID: 18496733 structure and effects to sugar," and this is a discussion group, so how about some discussion? Sugar has 12 carbons; ascorbic acid has six. Sugar provides quick energy, ascorbic acid provides none. Most antioxidants are anti-inflammatory; ascorbic acid is an antioxidant, but you say it's "proinflammatory." Surely you realize this stuff is hard reading or incomprehensible to almost everybody in this newsgroup but you, so please help us understand what it says and why you said what you did. -- Marshall Price of Miami Known to Yahoo as d021317c |
| | |||
| |||
| "Taka" <taka0038[at]gmail.com> wrote in message news:82cab1e3-cdd6-4b8f-8620-c809ddec531b[at]b1g2000hsg.googlegroups.com... - quote - > Similar in structure and effects to sugar ...
Didn't understand a g-d thing in this abstract--or the point--but the reasonsugar and VitC are similar in structure is because Vit C is enzymatically biosynthesized from sugar, in most mammals, in relatively few steps. As is synthetic vitC, iirc. Not enyzymatically, as both r, s isomers are produced equally, but the starting material is sugar, which is why it was always pretty cheap. It probably is *still* pretty cheap, but since every g-d thing is now "branded" up the kazoo on the retail level, prices are probably artificially 10x higher than necessary. by the time it gets to our sorry retail asses. Why we and a few other species lost the ability to synthesize vit C is interesting evolutionary speculation. -- DT - quote - > Taka > > Mol Cell Biochem. 2008 May 22. > > Redox-active antioxidant modulation of lipid signaling in vascular > endothelial cells: vitamin C induces activation of phospholipase D > through phospholipase A(2), lipoxygenase, and cyclooxygenase. > > Steinhour E, Sherwani SI, Mazerik JN, Ciapala V, O'Connor Butler E, > Cruff JP, Magalang U, Parthasarathy S, Sen CK, Marsh CB, Kuppusamy P, > Parinandi NL. > Lipid Signaling and Lipidomics Laboratory, Division of Pulmonary, > Allergy, Critical Care, and Sleep Medicine, Department of Medicine, > College of Medicine, The Ohio State University, Columbus, OH, USA. > > We have earlier reported that the redox-active antioxidant, vitamin C > (ascorbic acid), activates the lipid signaling enzyme, phospholipase D > (PLD), at pharmacological doses (mM) in the bovine lung microvascular > endothelial cells (BLMVECs). However, the activation of phospholipase > A(2) (PLA(2)), another signaling phospholipase, and the modulation of > PLD activation by PLA(2) in the ECs treated with vitamin C at > pharmacological doses have not been reported to date. Therefore, this > study aimed at the regulation of PLD activation by PLA(2) in the > cultured BLMVECs exposed to vitamin C at pharmacological > concentrations. The results revealed that vitamin C (3-10 mM) > significantly activated PLA(2) starting at 30 min; however, the > activation of PLD resulted only at 120 min of treatment of cells under > identical conditions. Further studies were conducted utilizing > specific pharmacological agents to understand the mechanism(s) of > activation of PLA(2) and PLD in BLMVECs treated with vitamin C (5 mM) > for 120 min. Antioxidants, calcium chelators, iron chelators, and > PLA(2) inhibitors offered attenuation of the vitamin C-induced > activation of both PLA(2) and PLD in the cells. Vitamin C was also > observed to significantly induce the formation and release of the > cyclooxygenase (COX)- and lipoxygenase (LOX)-catalyzed arachidonic > acid (AA) metabolites and to activate the AA LOX in BLMVECs. The > inhibitors of PLA(2), COX, and LOX were observed to effectively and > significantly attenuate the vitamin C-induced PLD activation in > BLMVECs. For the first time, the results of the present study revealed > that the vitamin C-induced activation of PLD in vascular ECs was > regulated by the upstream activation of PLA(2), COX, and LOX through > the formation of AA metabolites involving oxidative stress, calcium, > and iron. > PMID: 18496733 |
|
#-1
| |||
| |||
| Similar in structure and effects to sugar ... Taka Mol Cell Biochem. 2008 May 22. Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: vitamin C induces activation of phospholipase D through phospholipase A(2), lipoxygenase, and cyclooxygenase. Steinhour E, Sherwani SI, Mazerik JN, Ciapala V, O'Connor Butler E, Cruff JP, Magalang U, Parthasarathy S, Sen CK, Marsh CB, Kuppusamy P, Parinandi NL. Lipid Signaling and Lipidomics Laboratory, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA. We have earlier reported that the redox-active antioxidant, vitamin C (ascorbic acid), activates the lipid signaling enzyme, phospholipase D (PLD), at pharmacological doses (mM) in the bovine lung microvascular endothelial cells (BLMVECs). However, the activation of phospholipase A(2) (PLA(2)), another signaling phospholipase, and the modulation of PLD activation by PLA(2) in the ECs treated with vitamin C at pharmacological doses have not been reported to date. Therefore, this study aimed at the regulation of PLD activation by PLA(2) in the cultured BLMVECs exposed to vitamin C at pharmacological concentrations. The results revealed that vitamin C (3-10 mM) significantly activated PLA(2) starting at 30 min; however, the activation of PLD resulted only at 120 min of treatment of cells under identical conditions. Further studies were conducted utilizing specific pharmacological agents to understand the mechanism(s) of activation of PLA(2) and PLD in BLMVECs treated with vitamin C (5 mM) for 120 min. Antioxidants, calcium chelators, iron chelators, and PLA(2) inhibitors offered attenuation of the vitamin C-induced activation of both PLA(2) and PLD in the cells. Vitamin C was also observed to significantly induce the formation and release of the cyclooxygenase (COX)- and lipoxygenase (LOX)-catalyzed arachidonic acid (AA) metabolites and to activate the AA LOX in BLMVECs. The inhibitors of PLA(2), COX, and LOX were observed to effectively and significantly attenuate the vitamin C-induced PLD activation in BLMVECs. For the first time, the results of the present study revealed that the vitamin C-induced activation of PLD in vascular ECs was regulated by the upstream activation of PLA(2), COX, and LOX through the formation of AA metabolites involving oxidative stress, calcium, and iron. PMID: 18496733 |
| Tags |
| pla2, proinflammatory, release, triggers, vitc |
Similar Threads | ||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Brain Iron Triggers Neuronal Death ironjustice: Prog Neurobiol. 2007 Aug 7; Brain iron metabolism: Neurobiology and neurochemistry. Ke Y, Qian ZM. Department of Physiology, Faculty of Medicine, The Chinese University of Hong Kong, NT, Hong Kong. New findings obtained during the past... | ironjustice | Nutrition | 3 | 09-21-2007 07:27 PM |
| Mercury Triggers Premature Birth Jan Drew: http://times.hankooki.com/lpage/nation/200610/kt2006103018275111960.htm Mercury Triggers Premature Birth Excerpt: The more mercury pregnant women are exposed to, the greater chance they have of giving premature birth to babies, according to... | Jan Drew | Dentistry | 2 | 11-20-2006 04:31 AM |
| High glycemic index carbohydrate mediates an acute proinflammatory process as measured by NF-kappaB activation. Just Cocky: For those that still think consumption of sugar is not pro-inflamatory: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16326481&query_hl=16 | Just Cocky | Nutrition | 1 | 12-09-2005 09:43 PM |
| Excess iron triggers or exacerbates multiple sclerosis ironjustice@aol.com: http://www.gmu.edu/news/gazette/0201/noveliron.html Excess iron also lowers the immune system and has been found to trigger or exacerbate Alzheimer's disease, multiple sclerosis, Parkinson's disease, among other conditions, according to the... | ironjustice@aol.com | Nutrition | 8 | 01-05-2005 03:54 PM |
| Re: Iron Faggot News Release markd@toad-net.com: This is uncalled for for any reason. There are multiple fatal flaws in his thesis, but this personal attack does nothing for it's poster but evoke pity and distain. >Let's hear more FAKE news from that queer jew with AIDs, the "veggie". | markd@toad-net.com | Nutrition | 2 | 12-07-2004 02:17 AM |
| Thread Tools | |
| Display Modes | |
| |